9EO6
SARS-CoV2 major protease in complex with a covalent inhibitor SLL11.
This is a non-PDB format compatible entry.
Summary for 9EO6
Entry DOI | 10.2210/pdb9eo6/pdb |
Descriptor | 3C-like proteinase nsp5, ~{N}-[(2~{S})-3-cyclobutyl-1-[[(2~{R})-1-(1~{H}-indol-3-yl)-4-[[(2~{R})-1-(methylamino)-1-oxidanylidene-3-pyridin-4-yl-propan-2-yl]amino]-4-oxidanylidene-butan-2-yl]amino]-1-oxidanylidene-propan-2-yl]-2-(iminomethyl)pyridine-4-carboxamide, POTASSIUM ION, ... (4 entities in total) |
Functional Keywords | inhibitor complex, antiviral protein |
Biological source | Severe acute respiratory syndrome coronavirus 2 |
Total number of polymer chains | 6 |
Total formula weight | 206969.23 |
Authors | Moche, M.,Lennerstrand, J.,Nyman, T.,Strandback, E.,Akaberi, D. (deposition date: 2024-03-14, release date: 2024-09-04) |
Primary citation | Akaberi, D.,Pourghasemi Lati, M.,Krambrich, J.,Berger, J.,Neilsen, G.,Strandback, E.,Turunen, S.P.,Wannberg, J.,Gullberg, H.,Moche, M.,Chinthakindi, P.K.,Nyman, T.,Sarafianos, S.G.,Sandstrom, A.,Jarhult, J.D.,Sandberg, K.,Lundkvist, A.,Verho, O.,Lennerstrand, J. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrob.Agents Chemother., :e0090924-e0090924, 2024 Cited by PubMed: 39194208DOI: 10.1128/aac.00909-24 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.11 Å) |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)